NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|10|1|9-19

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.1, 2009-01, pp. : 9-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Marked neuropeptide Y-induced contractions via NPY-Y 1 receptor and its desensitization in rat veins

By Tsurumaki T.   Yamaguchi T.   Higuchi H.  

General Pharmacology, Vol. 39, Iss. 6, 2002-12 ,pp. : 325-333

Elsevier

Access to resources Recommend Favorite

NPY Y1 and Y5 Receptor Selective Antagonists as Anti-Obesity Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 17, 2007-01 ,pp. : 1721-1733

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological characterization of human NPFF 1 and NPFF 2 receptors expressed in CHO cells by using NPY Y 1 receptor antagonists

By Mollereau C.   Mazarguil H.   Marcus D.   Quelven I.   Kotani M.   Lannoy V.   Dumont Y.   Quirion R.   Detheux M.   Parmentier M.   Zajac J.-M.  

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 245-256

Elsevier

Access to resources Recommend Favorite

The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 267-281

Bentham Science Publishers

Access to resources Recommend Favorite

The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1335-1340

Bentham Science Publishers

Access to resources Recommend Favorite